PCSK9 and familial hyperaldosteronism: It has also been shown that in FH patients with the LDLR mutation in the Japanese population, the addition of the PCSK9 gain-of-function (GOF) genetic variant is accompanied by an increase in PCSK9 and LDL-C levels (16).